anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 23,941-23,970
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

23,941-23,970 of 43,093

filter-aware
20
The slide explicitly notes that these are cross-trial comparisons, not head-to-head studies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
21
Includes detailed source citations and disclaimer regarding cross-trial comparisons.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
22
The slide uses a comparison table framework to highlight NXC-201's competitive advantage in safety (lower ICANS/CRS) and efficacy (higher ORR/CR).Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
23
The slide uses a two-column layout to contrast clinical results for Multiple Myeloma vs. AL Amyloidosis, supported by market data for existing therapies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
45
Immix Biopharma | Investor Presentation Deck | 52 slidesImmix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Team1 hit
46
The slide is divided into two sections: ImmixBio Clinical Advisory Board (top) and Select Nexcella Scientific Advisory Board Members (bottom).Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Team1 hit
47
Immix Biopharma | Investor Presentation Deck | 52 slidesImmix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Team1 hit
48
Immix Biopharma | Investor Presentation Deck | 52 slidesImmix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Team1 hit
17
Includes footnotes regarding financial projections and conference schedule.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
03
The slide uses a corporate branding background with a watermark logo.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Problem1 hit
04
The slide uses a hub-and-spoke diagram to center the 'Building Owners' as the primary focus of the company's operations.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Problem1 hit
06
Limbach Holdings | Investor Presentation Deck | 27 slidesLimbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide uses a path metaphor to contrast Limbach's focus on optimization against competitors focused on new construction (changing skylines).Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a checkmark/cross matrix to demonstrate competitive differentiation.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a 2x2 matrix to illustrate a strategic shift from a 'Specialty Contractor' profile to an 'Engineering/OEM' profile.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a process-flow visual to link specific market segments to broader economic themes like 'Mission-Critical', 'Durable Demand', and 'Economic Resilience'.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
12
The slide uses a maturity model framework (Limbach 1.0 to 3.0) to illustrate business model evolution.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
13
The chart uses a dual-axis approach to correlate margin expansion with ODR revenue mix shift.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
14
Uses a funnel-like diagram leading into a Venn-style hub-and-spoke model.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
15
The slide outlines two distinct M&A strategies: tuck-ins for existing markets and new geography expansion.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
16
Mentions '80/20 mindset' which refers to the Pareto Principle.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
18
Includes standard financial disclaimer footnotes.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
19
Limbach Holdings | Investor Presentation Deck | 27 slidesLimbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
20
Limbach Holdings | Investor Presentation Deck | 27 slidesLimbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
21
The slide uses stacked bar charts to break down performance by GCR and ODR segments.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
22
The slide uses stacked bar charts to show segment contributions (GCR vs ODR) and simple bar charts for EBITDA.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
23
Includes footnotes explaining the calculation of net debt and references to SEC filings.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
24
Includes detailed footnotes regarding the use of non-GAAP measures and specific restructuring costs.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
25
Includes detailed line-item adjustments such as stock-based compensation, debt modification losses, and transition costs.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
26
Includes footnotes regarding EBITDA reconciliation and FCF definition.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit